Market Moves: Supplement industry deals of Q3 2026
Procter & Gamble agreed to acquire Thorne for $3.8B, expanding its health portfolio. Yellow Wood Partners bought Nestlé’s Holistic Health for $1B. Other deals include Fullscript’s majority stake sale, Wellma’s acquisition of Virun, and Kirin’s purchase of Jamieson Wellness for C$2.5B. Transactions highlight trends in premium wellness, supply chain control, and global expansion.
How this was made
The 30-second read
Why it matters
The acquisition positions P&G in the fast‑growing premium supplement space, offering cross‑selling opportunities and expanding its health‑care portfolio.
Market read
A major M&A move in the health‑care consumer sector that could reshape competitive dynamics.
What to watch
Potential regulatory scrutiny and integration risk in a niche supplement market.
Background
The article is a quarterly roundup of supplement‑industry M&A, with P&G's Thorne deal as the headline transaction.
Ticker impact
Procter & Gamble announced a $3.8 billion acquisition of premium supplement brand Thorne, expanding its health portfolio.
likely upward pressure as investors price in the strategic fit and revenue upside
Large‑cap M&A with clear strategic rationale; first report of the transaction.
Market effects
Adds competitive pressure on other supplement and consumer‑health companies, may spur further consolidation.
Strengthens P&G's presence in North American health‑care market.
Highlights growing investor interest in premium nutrition and wellness brands.
Counterpoint
Deal could dilute P&G's focus on core consumer staples and stretch integration capabilities.
Key entities
- CompanyProcter & Gamble
US consumer‑goods giant executing the acquisition.
- CompanyThorne
Premium supplement brand being acquired.
